Literature DB >> 1164215

Cerebral blood flow in dementia.

V C Hachinski, L D Iliff, E Zilhka, G H Du Boulay, V L McAllister, J Marshall, R W Russell, L Symon.   

Abstract

Twenty-four patients of comparable age, blood pressure, and degree of dementia were classified by an "Ischemic Score" based on clinical features into "multi-infarct" and "primary degenerative" dementia. Regional cerebral blood flow (CBF) was measured by the intracarotid xenon 133 method. Both groups showed a decreased proportion of rapidly clearing brain tissue (largely gray matter). Cerebral blood flow per 100 gm brain per minute was normal in the primary degenerative group but low in the multi-infarct group. This suggests the blood flow is adequate for metabolic needs of the brain in patients with primary degenerative dementia but inadequate for those with multi-infarct dementia. There was no correlation between degree of dementia and CBF in the primary degenerative group but an inverse relationship existed in the multi-infarct group. Reactivity of blood vessels to reduction of arterial carbon dioxide pressure was normal in both groups.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1164215     DOI: 10.1001/archneur.1975.00490510088009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  436 in total

1.  Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study.

Authors:  V Rondeau; D Commenges; H Jacqmin-Gadda; J F Dartigues
Journal:  Am J Epidemiol       Date:  2000-07-01       Impact factor: 4.897

2.  Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia.

Authors:  H Hanyu; T Asano; T Iwamoto; M Takasaki; H Shindo; K Abe
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

3.  Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.

Authors:  Stephanie L Adams; Laurent Benayoun; Kathy Tilton; Olivia R Chavez; Jayandra J Himali; Jan Krzysztof Blusztajn; Sudha Seshadri; Ivana Delalle
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Normative data of a brief neuropsychological battery for Spanish individuals older than 49.

Authors:  Montserrat Alegret; Ana Espinosa; Georgina Vinyes-Junqué; Sergi Valero; Isabel Hernández; Lluís Tárraga; James T Becker; Mercè Boada
Journal:  J Clin Exp Neuropsychol       Date:  2011-12-13       Impact factor: 2.475

Review 5.  [Arterial hypertension and dementia].

Authors:  R Scheid; H Voigt
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

6.  Association between exposure to anaesthesia and surgery and long-term cognitive trajectories in older adults: report from the Mayo Clinic Study of Aging.

Authors:  P J Schulte; R O Roberts; D S Knopman; R C Petersen; A C Hanson; D R Schroeder; T N Weingarten; D P Martin; D O Warner; J Sprung
Journal:  Br J Anaesth       Date:  2018-06-27       Impact factor: 9.166

7.  The Hachinski ischemic scale and cognition: the influence of ethnicity.

Authors:  Leigh A Johnson; Blair Cushing; Geoffrey Rohlfing; Melissa Edwards; Hedieh Davenloo; Darrin D'Agostino; James R Hall; Sid E O'Bryant
Journal:  Age Ageing       Date:  2013-12-08       Impact factor: 10.668

8.  A comparison of Tc-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia.

Authors:  H G Gemmell; P F Sharp; J A Besson; K P Ebmeier; F W Smith
Journal:  Eur J Nucl Med       Date:  1988

9.  Perivascular deposits of serum proteins in cerebral cortex in vascular dementia.

Authors:  I Alafuzoff; R Adolfsson; I Grundke-Iqbal; B Winblad
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

10.  The effects of bromvincamine and vincamine on regional cerebral blood flow and mental functions in patients with multi-infarct dementia.

Authors:  S Hagstadius; L Gustafson; J Risberg
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.